Evidence map›Paper›PMID 39954118›Full record

SynthesisCNS drugs2025

Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS): A Comprehensive Meta-Analysis of Ethnicity, Socioeconomic Status, and Geographical Factors.

Raisa Biswas, Tissa Wijeratne, Kamil Zelenak, Bella B Huasen, Marta Iacobucci, Murray C Killingsworth, Roy G Beran, Mehari Gebreyohanns, Alakendu Sekhar, Dheeraj Khurana and 3 more

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in CNS drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Transcranial direct current stimulation is safe and feasible in hyperacute ischemic stroke (DICAST-SF trial).Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Trial
  2. Article
  3. Article
  4. Real world outcomes of reperfusion treatments in acute ischemic stroke (AIS): a prospective cohort study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Raisa BiswasGlobal Health Neurology Lab, Sydney, NSW, 2150, Australia.
Tissa WijeratneMelbourne Medical School, Department of Medicine and Neurology, University of Melbourne and Western Health, St Albans, VIC, 3021, Australia.ORCID 0000-0002-1701-7111
Kamil ZelenakDepartment of Radiology, Comenius University's Jessenius Faculty of Medicine and University Hospital, Martin, Slovakia.ORCID 0000-0002-0416-2985
Bella B HuasenDepartment of Interventional Neuroradiology, Lancashire University Teaching Hospitals, Preston, England.
Marta IacobucciDepartment of Human Neurosciences, Interventional Neuroradiology Unit, University Hospital "Umberto I", Rome, Italy.ORCID 0000-0002-3911-3278
Murray C KillingsworthUniversity of New South Wales (UNSW), UNSW Medicine and Health, South West Sydney Clinical Campuses, Sydney, NSW, 2170, Australia.ORCID 0000-0002-6125-1183
Roy G BeranGlobal Health Neurology Lab, Sydney, NSW, 2150, Australia.ORCID 0000-0002-5884-0606
Mehari GebreyohannsDepartment of Neurology, The University of Texas Southwestern Medical Center, Dallas, Texas, TX, 75390, USA.
Alakendu SekharThe Walton Centre NHS Foundation Trust, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.ORCID 0000-0002-9997-5654
Dheeraj KhuranaDepartment of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0000-0002-5379-3089
Thanh N NguyenDepartment of Interventional Neurology and Neuroradiology, Boston University Chobanian and Avedisian School of Medicine (BUSM), Boston, MA, USA.ORCID 0000-0002-2810-1685
Pascal M JabbourDivision of Neurovascular Surgery and Endovascular Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA, USA.ORCID 0000-0002-2652-2451
Sonu M M BhaskarGlobal Health Neurology Lab, Sydney, NSW, 2150, Australia. Sonu.Bhaskar@globalhealthneurolab.org.ORCID 0000-0002-9783-3628

Funding

Japan Society for the Promotion of Science London P23712
6 · The paper itself

Abstract

backgroundReperfusion therapies, such as intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT), are crucial for improving outcomes in patients with acute ischemic stroke (AIS). However, access to these treatments can vary significantly due to ethnicity, socioeconomic status (SES), and geographical location, impacting patient outcomes.

objectivesThe Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS) study aims to systematically assess disparities in access to IVT and EVT on the basis of ethnicity, SES, and geographical location.

methodsA comprehensive meta-analysis was conducted, incorporating data from 38 studies involving 5,256,531 patients with AIS. The analysis evaluated IVT and EVT utilization rates across ethnic groups, SES levels, and geographical locations.

resultsThe findings reveal substantial disparities in access to reperfusion therapies. IVT and EVT utilization rates varied significantly by ethnicity (9% ethnic, 11% non-ethnic for IVT; 7% ethnic, 6% non-ethnic for EVT), SES (13% low SES, 16% high SES for IVT; 7% low SES, 10% high SES for EVT), and geography (9% rural, 12% urban for IVT; 1% rural, 4% urban for EVT). Black patients had significantly lower odds of receiving IVT (OR 0.69, p = 0.001) and EVT (OR 0.87, p = 0.005) compared with white patients. Similarly, patients with low SES and those from rural areas faced reduced odds of receiving IVT (OR 0.74, p < 0.001; OR 0.72, p = 0.002) and EVT (OR 0.74, p < 0.001; OR 0.39, p < 0.001). Rural patients also had significantly lower odds of timely hospital arrival (p < 0.001), posing a barrier to accessing reperfusion therapies.

conclusionsThe DARTS study (and this meta-analysis) reveals significant access disparities in AIS treatment related to ethnicity, geography, and SES, particularly affecting Black communities, low SES individuals, and rural populations. Despite advances in reperfusion therapies, suboptimal implementation rates persist. To address these issues, we recommend the EQUITY framework: Educate, Ensure Quality, provide Universal Access, Implement Inclusive Policy Reforms, Enhance Timely Data Collection, and Yield Culturally Sensitive Care Practices. Adopting these recommendations will improve access, reduce disparities, and enhance stroke management and outcomes globally. Equitable access is essential for all eligible patients to fully benefit from reperfusion treatments.

Indexed as

Healthcare DisparitiesHealth Services AccessibilityIschemic StrokeThrombolytic TherapyEndovascular ProceduresEthnicityHumansReperfusionSocial ClassThrombectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.